Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
44.440
Open
42.060
VWAP
43.75
Vol
2.94M
Mkt Cap
7.59B
Low
42.060
Amount
128.63M
EV/EBITDA(TTM)
9.94
Total Shares
179.98M
EV
8.22B
EV/OCF(TTM)
12.65
P/S(TTM)
1.58
Genpact Limited is an advanced technology services and solutions company. Its Financial Services segment offers services to clients in the banking, capital markets and insurance sectors. Its core operations services for these clients include customer onboarding, customer service, collections, retail and commercial loan operations, and others. Its Consumer and Healthcare segment offers services to clients in the consumer goods, retail, life sciences and healthcare sectors. The core operations services for these clients include demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, and others. Its High Tech and Manufacturing segment offers services to clients in the high tech hardware, high tech software and manufacturing sectors. Its core operations services for these clients include industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and others.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
1.27B
+4.51%
0.899
+5.81%
1.29B
+3.02%
0.928
+1.97%
1.27B
+4.81%
0.900
+7.13%
Estimates Revision
The market is revising Upward the revenue expectations for Genpact Limited (G) for FY2025, with the revenue forecasts being adjusted by 0.42% over the past three months. During the same period, the stock price has changed by 0.00%.
Revenue Estimates for FY2025
Revise Upward
+0.42%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+0.76%
In Past 3 Month
Stock Price
No Change
0.00%
In Past 3 Month
9 Analyst Rating
16.86% Upside
Wall Street analysts forecast G stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for G is 50.88 USD with a low forecast of 47.00 USD and a high forecast of 56.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
5 Hold
0 Sell
Moderate Buy
16.86% Upside
Current: 43.540
Low
47.00
Averages
50.88
High
56.00
16.86% Upside
Current: 43.540
Low
47.00
Averages
50.88
High
56.00
Needham
Mayank Tandon
Buy
maintain
$50 -> $53
2025-08-08
New
Reason
Needham
Mayank Tandon
Price Target
$50 -> $53
2025-08-08
New
maintain
Buy
Reason
Needham analyst Mayank Tandon raised the firm's price target on Genpact to $53 from $50 and keeps a Buy rating on the shares. The company posted solid Q2 results, beating estimates on all fronts, given broad-based demand improvement through the quarter, especially for Genpact's AI-based solutions, the analyst tells investors in a research note.
Baird
Neutral
maintain
$50 -> $52
2025-08-08
New
Reason
Baird
Price Target
$50 -> $52
2025-08-08
New
maintain
Neutral
Reason
Baird raised the firm's price target on Genpact to $52 from $50 and keeps a Neutral rating on the shares. The firm updated its model following Q2 results.
Deutsche Bank
Hold
maintain
$47
2025-07-17
Reason
Deutsche Bank
Price Target
$47
2025-07-17
maintain
Hold
Reason
Deutsche Bank resumed coverage of Genpact with a Hold rating and $47 price target. The firm resumed coverage on 25 stocks in the payments, processors, and IT services industry with nine Buys, 14 Holds, and two restricted ratings. Both industries have materially underperformed the S&P 500 Index year-to-date as investor expectations increased around the November election, leading to an end of year run-up \"that has since proven overly-optimistic,\" the analyst tells investors in a research note. The firm says that with trade uncertainty and consumer spending concerns, the outlook for the group \"is as cloudy as it has been in the last five years.\" In this uncertain environment, Deutsche favors \"high-quality compounders\" with consistent sales growth, margin expansion, and free cash flow generation.
Mizuho
Dan Dolev
Neutral
maintain
$48 -> $51
2025-07-01
Reason
Mizuho
Dan Dolev
Price Target
$48 -> $51
2025-07-01
maintain
Neutral
Reason
Mizuho analyst Dan Dolev raised the firm's price target on Genpact to $51 from $48 and keeps a Neutral rating on the shares following the company's recent investor day meeting, where management provided a medium-term financial framework as well as new key performance indicators to track the company's progress. The firm was "encouraged" by the greater detail on the company's go-forward AI strategy, although it remains at Neutral as the firm argues that "it is still early days."
TD Cowen
Buy
upgrade
$53 -> $55
2025-06-27
Reason
TD Cowen
Price Target
$53 -> $55
2025-06-27
upgrade
Buy
Reason
TD Cowen raised the firm's price target on Genpact to $55 from $53 and keeps a Buy rating on the shares. The firm said its investor day produced, a healthy yet prudent med-term outlook that reflects higher revenue and EPS growth versus FY26E Street, favorable net impacts on GenAI/agentic adoption and a proactive strategy that disrupts its core business paired with an active roadmap. At discounted valuation, Cowen thinks it's the catalyst to restart momentum in the shares.
Baird
Neutral
downgrade
$56 -> $50
2025-05-08
Reason
Baird
Price Target
$56 -> $50
2025-05-08
downgrade
Neutral
Reason
Baird lowered the firm's price target on Genpact to $50 from $56 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Genpact Ltd (G.N) is 11.85, compared to its 5-year average forward P/E of 15.19. For a more detailed relative valuation and DCF analysis to assess Genpact Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
15.19
Current PE
11.85
Overvalued PE
18.52
Undervalued PE
11.87
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
10.61
Current EV/EBITDA
8.09
Overvalued EV/EBITDA
12.44
Undervalued EV/EBITDA
8.79
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
1.74
Current PS
1.41
Overvalued PS
2.05
Undervalued PS
1.42
Financials
Annual
Quarterly
FY2025Q2
YoY :
+6.65%
1.25B
Total Revenue
FY2025Q2
YoY :
+6.14%
180.71M
Operating Profit
FY2025Q2
YoY :
+8.79%
132.72M
Net Income after Tax
FY2025Q2
YoY :
+11.94%
0.75
EPS - Diluted
FY2025Q2
YoY :
-19.35%
152.76M
Free Cash Flow
FY2025Q2
YoY :
+1.98%
35.53
Gross Profit Margin - %
FY2025Q2
YoY :
+13.79%
11.39
FCF Margin - %
FY2025Q2
YoY :
+2.03%
10.58
Net Margin - %
FY2025Q2
YoY :
-26.41%
14.52
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
664.9K
USD
1
6-9
Months
1.6M
USD
4
0-12
Months
4.3M
USD
6
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 805.73% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
3.3M
Volume
4
6-9
Months
362.9K
Volume
2
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
140.2K
Volume
Months
6-9
6
1.8M
Volume
Months
0-12
1
3.0K
Volume
Months
Congress Trading
Congress areSelling! The selling amount has increased100%over the last month.
Sold
0-3
Months
65.0K
USD
2
3-6
Months
32.5K
USD
1
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
664.9K
USD
1
6-9
Months
1.6M
USD
4
0-12
Months
4.3M
USD
6
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
G News & Events
Events Timeline
2025-08-07 (ET)
2025-08-07
16:41:16
Genpact raises FY25 adjusted EPS view to $3.51-$3.58 from $3.41-$3.52
2025-08-07
16:40:18
Genpact sees Q3 adjusted EPS 89c-90c, consensus 88c
2025-08-07
16:39:34
Genpact reports Q2 adjusted EPS 88c, consensus 85c
Sign Up For More Events
Sign Up For More Events
News
7.0
08-08SeekingAlphaGenpact raises 2025 revenue growth outlook to 4-6% amid rapid AI adoption and strong pipeline
9.5
08-07NASDAQ.COMGenpact (G) Q2 EPS Jumps 11%
8.0
08-07NASDAQ.COMStrategy To YieldBoost Genpact To 66.2% Using Options
Sign Up For More News
People Also Watch
AAPL
Apple Inc
229.350
USD
+4.24%
WMT
Walmart Inc
103.730
USD
+0.59%
TSLA
Tesla Inc
329.650
USD
+2.29%
META
Meta Platforms Inc
769.300
USD
+0.98%
GOOGL
Alphabet Inc
201.420
USD
+2.49%
NVDA
NVIDIA Corp
182.700
USD
+1.07%
MSFT
Microsoft Corp
522.040
USD
+0.23%
AMZN
Amazon.com Inc
222.690
USD
-0.20%
AVGO
Broadcom Inc
304.970
USD
+0.40%
GOOG
Alphabet Inc
202.090
USD
+2.44%
FAQ
What is Genpact Ltd (G) stock price today?
The current price of G is 43.54 USD — it has increased 4.36 % in the last trading day.
What is Genpact Ltd (G)'s business?
What is the price predicton of G Stock?
What is Genpact Ltd (G)'s revenue for the last quarter?
What is Genpact Ltd (G)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Genpact Ltd (G)'s fundamentals?
How many employees does Genpact Ltd (G). have?